PCA3 is significantly elevated in patients with prostate cancer, and several available studies show the utility of PCA3, as a urinary biomarker, for the diagnosis of early prostate cancer with reasonable specificity and sensitivity [61,62]. Here, PCA3 is linked to prostate cancer.